Skip to main content

Jaume Alijotas Reig

Institutions of which they are part

Head of group
Systemic Diseases
Vall Hebron Institut de Recerca

Jaume Alijotas Reig

Institutions of which they are part

Head of group
Systemic Diseases
Vall Hebron Institut de Recerca

Research lines

Immunological alterations as basis of inmunosenescencein pathological aging.

This research line is centered into the study of the role of cross-reactivity among oxidized lipoproteins (oxLDL), antiB2-GP1 and membrane phospholipids, as well as between these complexes and heat shock proteins. We also focus into the role of proinflamatory (IL2 / IL6 / TNFalpha) and anti-inflamatory (IL4 / IL-10) cytokines, as well as with the different activation profiles of TCR and/or CD14 (TLR4) and the role of hormones such as melatonin and the growth hormone.

IP: Jaume Alijotas Reig

Endothelial senescence and their pleiotropic effects onto inflamatory processes, inmunological response and angiogenesis.

Identification at the molecular level of pathways and proteins associated with the senescence of endothelial cells linked to aging and inflamatory responses. New candidate targets for therapeutic intervention at the clinical level and as new molecular moieties for nanomedicine approaches to improve aging related pathologies caused by endothelial inflamatory based senescence.

IP: Jaume Alijotas Reig

Projects

GLOBE: Gestación Ligada a Obesidad y al Entorno. Estudio longitudinal multicéntrico de factores de riesgo asociados a la obesidad en el embarazo

IP: -
Collaborators: Jaume Alijotas Reig, Inés Zulema Calero Fernández, Maite Avilés García
Funding agency: Instituto de Salud Carlos III
Funding: 135883
Reference: PI10/01367
Duration: 01/01/2011 - 31/12/2014

Heparina de Bajo Peso Molecular (HBPM) para la prevención de complicaciones derivadas de la insuficiencia placentaria en las pacientes de riesgo sin trombofilia: estudio multicéntrico randomizado

IP: -
Collaborators: Jaume Alijotas Reig, Inés Zulema Calero Fernández, Elisa Llurba Olivé, Josep Perapoch López
Funding agency: Ministerio Sanidad
Funding: 80000
Reference: EC10-205
Duration: 01/01/2011 - 31/12/2016

Envejecimiento endotelial y sus efectos pleiotrópicos sobre procesos inflamatorios, de la respuesta inmune y angiogénesis

IP: Francesc Miro Mur
Collaborators: Jaume Alijotas Reig, Simon Schwartz Navarro
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 36000
Reference: FMMA/05/2008
Duration: 24/09/2008 - 23/09/2011

CIBER: Bioingenieria, biomateriales y nanomedicina

IP: -
Collaborators: Manuel López Cano, Jaume Alijotas Reig, Francesc Miro Mur, Eloy Espín Basany
Funding agency: CIBER Bioing., Biomateriales y Nanomedicina , BBN
Funding: 480000
Reference: CB06/01/0012
Duration: 01/01/2007 - 31/12/2010

Related news

15 researchers from the Rheumatology, Systemic Diseases and the Physiology and Pathophysiology of the Digestive Tract groups gave around 25 presentations.

The new technology allows more sensitive detection of scleroderma patients' autoantibodies, which are related to the severity and progression of the disease.

Researchers have used an innovative protocol to identify people with this autoimmune disease who have a higher risk of cancer.

Related professionals

Victor José Gallardo Lopez

Victor José Gallardo Lopez

Main researcher
Headache and Neurological Pain
Read more
Susana Anfosso Llopis

Susana Anfosso Llopis

Infectious Diseases
Read more
Clara Carnicer Cáceres

Clara Carnicer Cáceres

Postdoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Anna Maria Cueto Gonzalez

Anna Maria Cueto Gonzalez

Main researcher
Genetics Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.